SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
This additional acquisition in Spain market increases DESMA Spain’s footprint and business.
SIT PHARMA acquires OSTIDIL-D3 and KEFORAL
SIT PHARMA is pleased to announce the acquisition of OSTIDIL-D3 and KEFORAL
SIT Pharma acquires DERINOX® for France market
SIT Pharma is pleased to announce the acquisition of DERINOX® from Therabel Lucien Pharma Sas
SIT Pharma acquires MIZOLLEN® for France market
SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED